A New Jersey Jury has awarded a South Dakota woman $3.35 million dollars in the first vaginal mesh case to go to trial against Johnson & Johnson regarding the Ethicon mesh, reports Reuters.
A federal judge in Charleston, West Virginia has set the first Bard vaginal mesh case for trial next February, reports Bloomberg News.
The U.S. FDA issued a report last year finding that vaginal mesh products should be classified as posing a high risk to patients based on its review of side-effect reports. The mesh products are inserted vaginally and used to stop pelvic organs from bulging, called prolapse. They are also used in treating incontinence.
If you think you have been injured by a vaginal mesh product, whether manufactured by Bard, Johnson & Johnson or others, please contact our office to discuss a possible claim.